Skip to content

Research on effectiveness of behavioral activation therapy for Japanese cancer patients with depression

Research on effectiveness of behavioral activation therapy for Japanese cancer patients with depression - Research on effectiveness of behavioral activation therapy for Japanese cancer patients with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036104
Enrollment
32
Registered
2019-03-06
Start date
2018-02-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cancer patients with depression

Interventions

The intervention program consisted of seven 50-minute sessions conducted over 1 or 2 weeks, with an average of 5 to 10 minutes of homework per day.

Sponsors

Department of Psycho-Oncology, National Cancer Center Hospital, Japan
Lead Sponsor
Faculty of Human Sciences, Waseda University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Somatic disease: patients whose prognosis is expected for more than 1 year Mental disorders: meet the diagnosis criteria for major depression episode by Mini-International Neuropsychiatric Interview(M.I.N.I.) Severity of mental disorders: more than 8 points in HRSD (depressive severity at mild and above levels) Age: over 20(patients aged 65 and older must have at least 24 points with MMSE.) PS: 0-1 by ECOG performance status score Language: capable of Japanese Assent: obtain assent for taking part in the research in writing

Exclusion criteria

Exclusion criteria: they show either serious physical or mental symptoms (cognitive functional disorders,disturbance of consciousness, depressive conditions accompanied with psychiatric symptoms, imminent suicidal ideation, and/or record of contemplation of suicide) they have experienced intervention by experts in the past such as behavioral activation therapy the physicians in charge judge it difficult for their patients to participate in the program

Design outcomes

Primary

MeasureTime frame
Remission rate of depression based on Hamilton Rating Scale for depression

Secondary

MeasureTime frame
Beck Depression Inventory-2 Generalized Anxiety Disorder-7 Functional Assessment of Cancer Therapy-General Behavioral Activation for Depression Scale-Short Form Valuing Questionnaire Reward Probability Index Completion rate of the intervention program Questionnaires before and after the intervention

Countries

Japan

Contacts

Public ContactTakatoshi Hirayama

National Cancer Center Hospital, Japan Department of Psycho-Oncology

thirayam@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026